Case Control Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Sep 28, 2017; 23(36): 6674-6684
Published online Sep 28, 2017. doi: 10.3748/wjg.v23.i36.6674
Table 2 Distribution of gene polymorphisms in patients with hepatocellular carcinoma, in hepatitis B/hepatitis C -positive patients, and in healthy controls n (%)
GeneSNPGenotypeHCC groupHBV/HCV groupHealthy group
ERCC1rs3212986GG126 (67.7)82 (49.1)91 (47.4)
GT44 (23.7)78 (46.7)81 (42.2)
TT16 (8.6)7 (4.2)20 (10.4)
XRCC3rs1799794AA128 (66.7)108 (65.1)137 (71.7)
AG52 (27.1)55 (33.1)49 (25.7)
GG12 (6.3)3 (1.8)5 (2.6)
GST-P1rs1138272CC172 (92.5)139 (83.2)182 (94.8)
CT13 (7.0)27 (16.2)10 (5.2)
TT1 (0.5)1 (0.6)0 (0.0)
CYP17A1rs743572TT72 (38.1)39 (23.4)54 (28.4)
TC84 (44.4)88 (52.7)91 (47.9)
CC33 (17.5)40 (24.0)45 (23.7)
ABCB1rs1128503CC54 (28.1)52 (31.1)58 (30.2)
CT92 (47.9)93 (55.7)95 (49.5)
TT46 (24.0)22 (13.2)39 (20.3)